BNP Paribas Asset Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
WA
BNP Paribas Asset Management's MEDP Position: Q2 2026 in Review
BNP Paribas Asset Management reduced its Medpace (MEDP) stake by 38% in Q2 2026, selling an estimated $5.41M and leaving 18,724 shares worth $9.92M. The position accounts for 0.01% of the portfolio, ranked #740.
BNP Paribas Asset Management first reported a position in MEDP in Q2 2025 and has held it in 5 quarters since. The position peaked at $14.6M in Q1 2026. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- BNP Paribas Asset Management held 18,724 shares of Medpace worth $9.92M as of Q2 2026.
- BNP Paribas Asset Management sold 11,713 Medpace shares in Q2 2026, an estimated $5.41M.
- Medpace made up 0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #740 holding.
- BNP Paribas Asset Management first reported a position in Medpace in Q2 2025 and has held it in 5 quarters since.
- BNP Paribas Asset Management's Medpace position peaked at $14.6M in Q1 2026.
- 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.